+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Vaccine Research Market 2024-2028 - Product Thumbnail Image

Vaccine Research Market 2024-2028

  • Report
  • August 2024
  • 170 Pages
  • Global
From
From
Bipolar Disorder Therapeutics Market 2024-2028 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 161 Pages
  • Global
From
From
Viral Hepatitis Market Report 2025 - Product Thumbnail Image

Viral Hepatitis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Dry Eye Medication Market - Global Forecast 2025-2030 - Product Thumbnail Image

Dry Eye Medication Market - Global Forecast 2025-2030

  • Report
  • November 2025
  • 199 Pages
  • Global
From
Bio-Pharma Market 2025-2029 - Product Thumbnail Image

Bio-Pharma Market 2025-2029

  • Report
  • June 2025
  • 229 Pages
  • Global
From
Dermatitis Market Report 2025 - Product Thumbnail Image

Dermatitis Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Heart Failure Software Market - Global Forecast 2025-2032 - Product Thumbnail Image

Heart Failure Software Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 199 Pages
  • Global
From
Irritable Bowel Syndrome Market 2024-2028 - Product Thumbnail Image

Irritable Bowel Syndrome Market 2024-2028

  • Report
  • November 2024
  • 209 Pages
  • Global
From
Human Vaccine Market 2024-2028 - Product Thumbnail Image

Human Vaccine Market 2024-2028

  • Report
  • November 2023
  • 166 Pages
  • Global
From
Clostridium Difficile Treatment - Global Strategic Business Report - Product Thumbnail Image

Clostridium Difficile Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 192 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 193 Pages
  • Global
From
Aspergillosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 373 Pages
  • Global
From
From
Aspergillosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 374 Pages
  • Global
From
Cryptococcosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 473 Pages
  • Global
From
Antifungal Treatment - Global Strategic Business Report - Product Thumbnail Image

Antifungal Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 590 Pages
  • Global
From
Candidiasis Therapeutics Market - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Therapeutics Market - Global Strategic Business Report

  • Report
  • December 2025
  • 474 Pages
  • Global
From
Loading Indicator